|
Market Closed -
NSE India S.E.
15:05:08 23/10/2026 +04
|
5-day change | 1st Jan Change | ||
| 211.76 INR | +0.43% |
|
-3.03% | +9.94% |
| Market Cap | 13.96B 147M 131M 121M 110M 206M 209M 1.46B 578M 7.31B 552M 540M 23.06B | P/E 2025 |
26.4x | P/E 2026 | 29.1x |
|---|---|---|---|---|---|
| Enterprise Value | 12.98B 137M 122M 113M 102M 191M 194M 1.36B 538M 6.8B 513M 502M 21.45B | EV / Sales 2025 |
4.92x | EV / Sales 2026 | 3.95x |
| Free-Float |
24.06% | Yield 2025 |
1.15% | Yield 2026 | 1.36% |
NSE India S.E.INR
| Markets | Quality | ||
|---|---|---|---|
NSE India S.E.
| JAGSNPHARM | Delayed | |
Bombay S.E.
| JAGSNPHARM | Delayed |
| 30/08/22 | Jagsonpal Pharmaceuticals : ESOP/ESPS/SBEB Scheme | PU |
| 16/08/22 | Jagsonpal Pharmaceuticals : Reply to Clarification Sought | PU |
| 16/07/22 | Jagsonpal Pharmaceuticals : Appointment | PU |
| 1 day | +0.43% | ||
| 1 week | -3.03% | ||
| Current month | -10.93% | ||
| 1 month | -13.20% | ||
| 3 months | -4.44% | ||
| 6 months | +6.31% | ||
| Current year | +9.94% |
| 1 week | 203.41 |  | 222.22 |
| 1 month | 203.41 | | 246.53 |
| Current year | 155 | | 264.5 |
| 1 year | 155 | | 264.5 |
| 3 years | 109.44 | | 328.04 |
| 5 years | 49.2 | | 328.04 |
| 10 years | 6.5 | | 328.04 |
| Manager | Title | Age | Since |
|---|---|---|---|
Manish Gupta
CEO | Chief Executive Officer | 59 | 16/07/2022 |
| Director of Finance/CFO | - | 07/10/2025 | |
Amrut Medhekar
COO | Chief Operating Officer | - | 04/09/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 69 | 04/12/2013 | |
Harsha Raghavan
CHM | Chairman | 55 | 16/07/2022 |
| Director/Board Member | - | 29/06/2022 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.43% | -3.03% | -1.78% | +30.31% | 147M | |
| -2.54% | +1.31% | +54.27% | +114.96% | 1,135B | |
| -1.42% | +3.23% | +38.56% | +74.44% | 635B | |
| +0.16% | +0.08% | +25.29% | +95.23% | 505B | |
| -0.31% | +3.09% | +44.14% | +64.80% | 378B | |
| -1.34% | -0.47% | +66.04% | +41.00% | 358B | |
| -0.68% | +2.65% | +22.98% | +50.39% | 295B | |
| -1.20% | +3.04% | +2.33% | +22.86% | 266B | |
| -1.79% | +1.57% | +50.56% | +59.08% | 237B | |
| -0.73% | -0.10% | +29.02% | +99.67% | 193B | |
| Average | -0.94% | +1.65% | +33.14% | +65.27% | 400.38B | |
| Weighted average by Cap. | -1.35% | +2.66% | +41.02% | +79.75% |
| 2025 | 2026 | |
|---|---|---|
| Net sales | 2.69B 28.31M 25.28M 23.35M 21.16M 39.59M 40.25M 281M 111M 1.41B 106M 104M 4.44B | 2.87B 30.26M 27.02M 24.96M 22.62M 42.32M 43.02M 300M 119M 1.5B 114M 111M 4.74B |
| Net income | 554M 5.83M 5.21M 4.81M 4.36M 8.16M 8.29M 57.89M 22.92M 290M 21.89M 21.42M 914M | 431M 4.54M 4.05M 3.74M 3.39M 6.35M 6.45M 45.05M 17.84M 226M 17.03M 16.67M 712M |
| Net Debt | -1.19B -12.59M -11.24M -10.38M -9.41M -17.61M -17.9M -125M -49.47M -626M -47.24M -46.24M -1.97B | -976M -10.29M -9.19M -8.49M -7.69M -14.39M -14.62M -102M -40.43M -512M -38.6M -37.78M -1.61B |
Employees
1,297
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 23/10/26 | ₹211.76 | +0.43% | 70,162 |
| 22/10/26 | ₹210.86 | -3.24% | 65,521 |
| 21/10/26 | ₹217.91 | +0.11% | 79,054 |
| 19/10/26 | ₹217.67 | -0.32% | 144,570 |
| 16/10/26 | ₹218.37 | -0.33% | 47,796 |
- Stock Market
- Stocks
- JAGSNPHARM Stock
Select your edition
All financial news and data tailored to specific country editions
